Special Session 2
3月26日［金］10:45-12:15
|
| |
| |
State of the Art Mechanisms of HFpEF
|
|
|
| |
| |
|
|
| |
左室駆出率が保たれた心不全患者が増加している。現時点でHFpEFに効果的な確立された治療法はない。HFpEFは多臓器連関、多臓器機能障害の視点で診る必要性があるが、その詳細な機序は解明されていない。このセッションでは国内外のエキスパートに最新知見を発表していただき、議論を深めたい。
|
|
|
| |
| |
|
|
| |
| |
 |
|
Yasuchika Takeishi
Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima
|
|
 |
|
Hendrikus L. Granzier
Cellular and Molecular Medicine, University of Arizona, Tucson, USA
|
|
|
| |
| |
|
|
| |
| |
|
|
Hendrikus L. Granzier
Cellular and Molecular Medicine, University of Arizona, Tucson, USA
|
|
 |
|
Gabriele G. Schiattarella
Cardiology, University of Texas Southwestern Medical Center, Dallas, USA
|
|
|
| |
| |
 |
|
Toshiyuki Nagai
Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo
|
|
 |
|
Akiomi Yoshihisa
Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima
|
|
|
| |
| |
 |
|
Shungo Hikoso
Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita
|
|
|
|
|
|
| |
| |
|
|